Shakti Singh
Investigator, Assistant Professor
The Lundquist Institute at Harbor-UCLA Medical Center, Torralnce, CA
David Geffen School of Medicine, University of California, Los Angeles, CA
Education:
2015, Ph.D. Experimental Surgery (Immunology), University of Alberta, Edmonton, Alberta, Canada
Academic Training :
2016 - 2017, Postdoctoral Research, National Cancer Institute (NIH), Frederick, MD
2017 - 2019, Postdoctoral Research, The Lundquist Institute, Torrance, CA
Area of Research:
Fungal Pathogenesis, Host-pathogen Interactions, Immunology, Diseases modeling, Vaccine, Immunotherapeutics and Antifungals
Website:
Publication List:
Email:
Biography
Dr. Singh is an Assistant Professor-in-Residence at The David Geffen School of Medicine at UCLA and an Investigator at the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center. His research is focused on Candida-host interaction, fungal virulence mechanisms, immunology, and vaccine/immunotherapeutic development for drug-resistant fungal infections.
Dr. Singh obtained his undergraduate (B.Sc.) in Biology and graduate degree (M.Sc.) in Microbiology from Chaudhary Charan Singh University, Meerut, India. Dr. Singh obtained his PhD in Experimental Surgery /Immunology in 2015 from the University of Alberta, Edmonton, Canada. Dr. Singh did his first postdoctoral research on HIV immunology and vaccine development at the National Cancer Institute at Frederick (NIH). Dr. Singh started his laboratory at The Lundquist Institute in 2022 after completing his second post-doctoral research on fungal pathogenesis and vaccine /immunotherapeutic development. Dr. Singh received grants from the American Heart Association, KL2 CTSI UCLA, and NIH (K01, R21/R33) for the ongoing research in his laboratory.